Jupiter Topco’s MBX Biosciences MBX Stock Holding History

Jupiter Topco’s Portfolio MBX Stock Details MBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$568K	Buy	+10,300	New	+$360K	﹤0.01%	2045

Other funds holding MBX

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Vanguard Capital Management

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Jupiter Topco's MBX Position: Q2 2026 in Review

Jupiter Topco opened a new position in MBX Biosciences (MBX) in Q2 2026: 10,300 shares worth $568K. The stake represents ﹤0.01% of the portfolio and ranks #2045 among its holdings.

158 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

Jupiter Topco held 10,300 shares of MBX Biosciences worth $568K as of Q2 2026.
MBX Biosciences was a new Jupiter Topco position in Q2 2026.
MBX Biosciences made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #2045 holding.
158 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.